Watson Pharmaceuticals, Inc. To Host Third Quarter 2006 Earnings Conference Call And Webcast

CORONA, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the Company intends to release its third quarter 2006 financial results on Tuesday, November 7, 2006 following the close of the U.S. financial markets. The Company will also host a conference call and webcast on November 7, 2006 at 5:00 p.m. Eastern Standard Time (EST) to discuss the results and provide an outlook for the rest of 2006. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.

A taped replay of the conference call will also be available beginning approximately two hours after the call’s conclusion and will remain available through 12:00 midnight EST on November 14, 2006. The replay may be accessed by dialing (800) 642-1687 and entering pass code 8563225. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same pass code. To access the webcast, go to Watson’s Investor Relations Web site at http://ir.watsonpharm.com. A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watsonpharm.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comWatson Pharmaceuticals, Inc.

CONTACT: Patty Eisenhaur of Watson Pharmaceuticals, Inc., +1-951-493-5611

MORE ON THIS TOPIC